Yahoo Web Search

Search results

  1. People also ask

  2. Clearmind develops novel psychedelic medicines to solve widespread—yet under-served—health problems. With a strong medical management and IP-protected treatments, we can better the lives of millions.

  3. www.clearmindmedicine.com › news-release › clearmindClearmind Medicine

    Mar 13, 2024 · Clearmind Medicine is a biotech company developing novel psychedelic-derived therapeutics for alcohol use disorder. It has received approval to start a phase I/IIa trial of its oral capsule CMND-100, a non-hallucinogenic molecule that reduces alcohol cravings.

  4. May 7, 2024 · Under the terms of the agreement, Clearmind receives exclusive rights to develop, manufacture, and commercialize novel compounds for treating PTSD and other mental health disorders.

  5. Mar 13, 2024 · Clearmind Medicine, a biotech company developing novel psychedelic-derived therapeutics, has received clearance from the Israeli Ministry of Health to start its phase I/IIa clinical trial for alcohol use disorder. The trial will evaluate the safety, pharmacokinetics and efficacy of CMND-100, a non-hallucinogenic oral capsule containing MEAI, in healthy volunteers and AUD patients.

  6. Nov 9, 2023 · Clearmind is a psychedelic pharmaceutical biotech company focused on the discovery and development of novel psychedelic-derived therapeutics to solve widespread and underserved health...

  7. Jan 10, 2024 · Clearmind is a psychedelic pharmaceutical biotech company focused on the discovery and development of novel psychedelic-derived therapeutics to solve widespread and underserved health...

  8. May 10, 2024 · Clearmind Medicine is a biotech company developing novel psychedelic-derived therapeutics, including a MEAI-based alcohol substitute beverage. The Company has completed most of the pre-clinical studies and has patents in the U.S., India and Europe for this product.

  1. People also search for